340B covered entities and drugmakers offered competing criticisms Thursday of the Health Resources and Services Administration’s (HRSA) newly released 340B [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
A majority of 340B hospitals surveyed said the costs associated with implementing drugmakers’ proposed rebate models would hinder their ability [...] …
The dark money group behind a campaign targeting GOP-led states’ recent efforts to enact 340B contract pharmacy access laws released [...] …
Two major drugmakers recently announced new states that will be exempt from their 340B contract pharmacy restrictions following their enactment [...] …
Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2025 following recalculations of [...] …
The debate over federal drug pricing reform could garner newfound attention on Capitol Hill now that Congress has wrapped up [...] …
News Alert
Matsui, Welch Reintroduce 340B PATIENTS Act in Congress During 340B Coalition Summer Conference
The two congressional Democrats behind the 340B PATIENTS Act—a 2024 federal bill that would’ve codified providers’ ability to use 340B [...] …
A key federal regulator highlighted the Health Resources and Services Administration’s (HRSA) legal fight against proposed drugmaker 340B rebate models [...] …
The leader of a major 340B hospital trade group heralded the forthcoming reintroduction of a federal bill that would codify [...] …
Two major drugmakers announced new changes to their 340B contract pharmacy restrictions in notices posted to 340B ESP’s website late [...] …